Dorsey Wright & Associates’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,400
Closed -$23.4K 280
2023
Q3
$23.4K Buy
+2,400
New +$19.2K 0.01% 215

Other funds holding ULBI

Dorsey Wright & Associates's ULBI Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of Ultralife (ULBI) in Q4 2023, closing a stake of 2,400 shares — an estimated $23.4K sold.

Dorsey Wright & Associates first reported a position in ULBI in Q3 2023 and held it in 1 quarter. The position peaked at $23.4K in Q3 2023. 54 funds tracked by Wall St. Rank hold ULBI as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining Ultralife position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,400 Ultralife shares in Q4 2023, an estimated $23.4K.
  • Dorsey Wright & Associates first reported a position in Ultralife in Q3 2023 and held it in 1 quarter.
  • Dorsey Wright & Associates's Ultralife position peaked at $23.4K in Q3 2023.
  • 54 funds tracked by Wall St. Rank held Ultralife as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.